Gibson Dunn advised Phillips 66 on the transaction. Phillips 66 (NYSE:PSX) announced that its subsidiary, Phillips 66 Limited, has entered into a definitive agreement to sell...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised Biosynth in the transaction. Biosynth, a portfolio company of KKR, announced its acquisition of celares GmbH. The terms and conditions of the...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher LLP advised New York-based investment company KKR & Co. Inc. (KKR) on its acquisition of Clinisupplies from Healthium. KKR was also advised...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised KnowBe4 and Potter Anderson & Corroon advised the Special Committee. Latham & Watkins represented Elephant Partners. Gibson, Dunn & Crutcher...
You must be a Standard 1 Year member to access this content.
Arthur Cox partnered with Gibson, Dunn & Crutcher LLP in advising Biosynth Carbosynth. Biosynth Carbosynth, a supplier of critical materials to the life science industry, on...
You must be a Standard 1 Year member to access this content.
Sidley, Homburger and Wolf Theiss advised KKR on the deal. Bär & Karrer acts as legal advisor to Armira and Dr. Urs Spitz in this transaction....
You must be a Standard 1 Year member to access this content.
Kromann Reumert and Sidley Austin LLP advised KKR on its purchase. Mazanti-Andersen advises the sellers. Nordic Bioscience A/S, a Danish company and world leader in biomarker...
You must be a Standard 1 Year member to access this content.
